bioAffinity Technologies (BIAF) Operating Leases: 2023-2025
Historic Operating Leases for bioAffinity Technologies (BIAF) over the last 2 years, with Sep 2025 value amounting to $375,139.
- bioAffinity Technologies' Operating Leases fell 24.95% to $375,139 in Q3 2025 from the same period last year, while for Sep 2025 it was $375,139, marking a year-over-year decrease of 24.95%. This contributed to the annual value of $469,596 for FY2024, which is 24.33% up from last year.
- bioAffinity Technologies' Operating Leases amounted to $375,139 in Q3 2025, which was down 7.90% from $407,313 recorded in Q2 2025.
- Over the past 5 years, bioAffinity Technologies' Operating Leases peaked at $499,849 during Q3 2024, and registered a low of $331,307 during Q2 2024.
- Moreover, its 3-year median value for Operating Leases was $398,260 (2023), whereas its average is $405,852.
- Per our database at Business Quant, bioAffinity Technologies' Operating Leases increased by 25.51% in 2024 and then fell by 24.95% in 2025.
- Over the past 3 years, bioAffinity Technologies' Operating Leases (Quarterly) stood at $377,709 in 2023, then increased by 24.33% to $469,596 in 2024, then declined by 24.95% to $375,139 in 2025.
- Its Operating Leases stands at $375,139 for Q3 2025, versus $407,313 for Q2 2025 and $438,757 for Q1 2025.